LaFleur & Godfrey LLC Invests $118,000 in Docusign Inc (NASDAQ:DOCU)

Share on StockTwits

LaFleur & Godfrey LLC purchased a new position in Docusign Inc (NASDAQ:DOCU) during the second quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 2,365 shares of the company’s stock, valued at approximately $118,000.

Several other institutional investors and hedge funds also recently modified their holdings of DOCU. BlackRock Inc. boosted its position in shares of Docusign by 98.2% in the 2nd quarter. BlackRock Inc. now owns 5,122,761 shares of the company’s stock worth $254,654,000 after purchasing an additional 2,537,764 shares in the last quarter. Wells Fargo & Company MN boosted its position in shares of Docusign by 173.7% in the 1st quarter. Wells Fargo & Company MN now owns 2,018,927 shares of the company’s stock worth $104,661,000 after purchasing an additional 1,281,178 shares in the last quarter. Artisan Partners Limited Partnership bought a new stake in shares of Docusign in the 1st quarter worth approximately $62,829,000. Morgan Stanley boosted its position in shares of Docusign by 73.7% in the 2nd quarter. Morgan Stanley now owns 2,440,441 shares of the company’s stock worth $121,314,000 after purchasing an additional 1,035,506 shares in the last quarter. Finally, Vanguard Group Inc. boosted its position in shares of Docusign by 12.9% in the 2nd quarter. Vanguard Group Inc. now owns 8,324,340 shares of the company’s stock worth $413,804,000 after purchasing an additional 950,343 shares in the last quarter. 68.79% of the stock is currently owned by hedge funds and other institutional investors.

A number of analysts have recently commented on DOCU shares. Citigroup boosted their price target on Docusign from $60.00 to $72.00 and gave the stock a “buy” rating in a research report on Friday, September 6th. FBN Securities set a $65.00 price target on Docusign and gave the stock a “buy” rating in a research report on Friday, September 6th. DA Davidson boosted their price target on Docusign to $63.00 and gave the stock a “buy” rating in a research report on Friday, September 6th. Royal Bank of Canada assumed coverage on shares of Docusign in a report on Friday, September 6th. They issued an “outperform” rating and a $75.00 price objective for the company. Finally, Wedbush upgraded shares of Docusign from a “neutral” rating to an “outperform” rating and boosted their price objective for the stock from $48.00 to $65.00 in a report on Friday, September 6th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and thirteen have assigned a buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus target price of $65.07.

Shares of NASDAQ DOCU opened at $64.80 on Friday. Docusign Inc has a twelve month low of $35.06 and a twelve month high of $65.07. The firm has a market cap of $11.14 billion, a P/E ratio of -22.34 and a beta of 1.37. The company has a 50 day moving average of $49.93 and a 200 day moving average of $52.67. The company has a quick ratio of 1.64, a current ratio of 1.64 and a debt-to-equity ratio of 1.06.

Docusign (NASDAQ:DOCU) last announced its quarterly earnings data on Thursday, September 5th. The company reported $0.01 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.23) by $0.24. Docusign had a negative net margin of 28.20% and a negative return on equity of 26.70%. The company had revenue of $235.61 million during the quarter, compared to analyst estimates of $220.81 million. During the same period in the previous year, the business earned $0.03 EPS. The firm’s revenue for the quarter was up 41.0% on a year-over-year basis. As a group, equities analysts expect that Docusign Inc will post -1.04 earnings per share for the current fiscal year.

In related news, COO Scott V. Olrich sold 4,000 shares of the business’s stock in a transaction that occurred on Monday, September 9th. The shares were sold at an average price of $58.98, for a total value of $235,920.00. Also, insider Kirsten O. Wolberg sold 7,877 shares of the business’s stock in a transaction on Tuesday, June 25th. The shares were sold at an average price of $50.93, for a total transaction of $401,175.61. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 590,230 shares of company stock valued at $30,659,814. 13.60% of the stock is owned by company insiders.

About Docusign

DocuSign, Inc provides cloud based software in the United States. The company offers e-signature solution that enables businesses to digitally prepare, execute, and act on agreements. The company sells its products through direct, partner-assisted, and Web-based sales. It serves enterprise businesses, commercial businesses, and small businesses, such as professionals, sole proprietorships and individuals.

Recommended Story: What economic reports are most valuable to investors?

Want to see what other hedge funds are holding DOCU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Docusign Inc (NASDAQ:DOCU).

Institutional Ownership by Quarter for Docusign (NASDAQ:DOCU)

Receive News & Ratings for Docusign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docusign and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

SOTHERLY HOTELS/SH SH  Upgraded by Zacks Investment Research to Hold
SOTHERLY HOTELS/SH SH Upgraded by Zacks Investment Research to Hold
Solaredge Technologies  Lowered to Hold at Zacks Investment Research
Solaredge Technologies Lowered to Hold at Zacks Investment Research
Resonant  Upgraded to “Hold” at Zacks Investment Research
Resonant Upgraded to “Hold” at Zacks Investment Research
Portola Pharmaceuticals  PT Lowered to $44.00
Portola Pharmaceuticals PT Lowered to $44.00
UltraNote Coin Reaches Market Cap of $13,486.00
UltraNote Coin Reaches Market Cap of $13,486.00
FS KKR Capital Corp  Receives $7.63 Consensus PT from Analysts
FS KKR Capital Corp Receives $7.63 Consensus PT from Analysts


© 2006-2019 Ticker Report